Skip to content
10-Q

Quarterly Report

AMPIO PHARMACEUTICALS, INC.

0001558370-23-008557

← back to feed
Filed
May 8, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 5, 2023 15.1M sh
Shares Diluted Q1 2023 · Mar 31, 2023 15.09M sh
Shares Diluted restated Q1 2023 · Mar 31, 2022 15.07M sh
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$2.3M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$4.94M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $10.35M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $12.65M
Stockholders Equity Q1 2023 · Mar 31, 2023 $7.88M
Stockholders Equity Q1 2023 · Dec 31, 2022 $11.79M
Stockholders Equity Q1 2023 · Mar 31, 2022 $22.25M
Stockholders Equity Q1 2023 · Dec 31, 2021 $27.28M
Current Liabilities Q1 2023 · Mar 31, 2023 $2.67M
Current Liabilities Q1 2023 · Dec 31, 2022 $1.19M
Total Liabilities Q1 2023 · Mar 31, 2023 $2.86M
Total Liabilities Q1 2023 · Dec 31, 2022 $1.8M
Current Assets Q1 2023 · Mar 31, 2023 $10.74M
Current Assets Q1 2023 · Dec 31, 2022 $13.33M
Total Assets Q1 2023 · Mar 31, 2023 $10.74M
Total Assets Q1 2023 · Dec 31, 2022 $13.59M
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.26
Eps Diluted restated Q1 2023 · Mar 31, 2022 −$0.46
Eps Basic Q1 2023 · Mar 31, 2023 −$0.26
Eps Basic restated Q1 2023 · Mar 31, 2022 −$0.37
Rd Expense Q1 2023 · Mar 31, 2023 $524K
Rd Expense Q1 2023 · Mar 31, 2022 $3.69M
Net Income Q1 2023 · Mar 31, 2023 −$3.98M
Net Income Q1 2023 · Mar 31, 2022 −$5.64M